Delivery Order SPE2DB22D3004-SPE2DB25FSH80
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. The contract is valued at $1,132.95 with a firm fixed price structure and is classified as a non-set-aside, competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 4, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical product with a ceiling value of $2,265.90. The award is classified as a Firm Fixed Price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $1,132.95 to supply HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used in the treatment of autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and was competitively awarded without set-aside designation. This award is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $7,659.60 to supply Humira Pen 40 mg/0.8 mL, with an ultimate completion date of November 10, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical product, with a ceiling value of $3,210.96. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by July 29, 2025. The place of performance is listed as AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,967.32 by the Defense Logistics Agency's Medical Supply Chain on June 25, 2025, for the supply of HUMIRA Pen 40mg/4ml in a quantity of two units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 7, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies, with a ceiling value of $9,205.12 and an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of...
- This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $10,754.36 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The contract, placed by the Defense Logistics Agency (DLA), has an ultimate completion date of August 7, 2024 and a firm fixed price pricing structure. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,597.60 by the Defense Logistics Agency on November 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...